From the Editor-in-Chief's Desk.
Child Mind Institute , New York, New York.
Harold S
HS
Koplewicz
D014150:Antipsychotic Agents / Q000009:adverse effects*; D001007:Anxiety / Q000150:complications / Q000188:drug therapy*; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002648:Child; D004565:Electroconvulsive Therapy; D006801:Humans; D065626:Non-alcoholic Fatty Liver Disease / Q000139:chemically induced*; D012559:Schizophrenia / Q000628:therapy*; D015430:Weight Gain / Q000187:drug effects*
D014150:Antipsychotic Agents; D000697:Central Nervous System Stimulants